{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:13:07Z","timestamp":1790172787952,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rdc.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T18:27:07Z","timestamp":1432664827000},"page":"507-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Musculoskeletal Manifestations of Systemic Sclerosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Kathleen B.","family":"Morrisroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2015.04.011_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.berh.2008.01.008","article-title":"Musculoskeletal involvement in systemic sclerosis","volume":"22","author":"Randone","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.011_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/ard.46.10.763","article-title":"A\u00a0new promising treatment in systemic sclerosis: 5-fluorouracil","volume":"46","author":"Casas","year":"1987","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/anr.1780320512","article-title":"Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study","volume":"32","author":"Furst","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.011_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard.60.12.1117","article-title":"Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale","volume":"60","author":"Geirsson","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1976.tb00855.x","article-title":"Thymus-dependent (T) lymphocyte deficiency in progressive systemic sclerosis","volume":"95","author":"Hughes","year":"1976","journal-title":"Br J Dermatol"},{"issue":"3 Suppl 29","key":"10.1016\/j.rdc.2015.04.011_bib6","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.011_bib7","first-page":"2159","article-title":"A\u00a0disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.011_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/rheumatology\/keq022","article-title":"Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis","volume":"49","author":"Minier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib9","first-page":"367","article-title":"Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis\u2013measuring functional impairment in systemic sclerosis versus other connective tissue diseases","volume":"25","author":"Morita","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.011_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.011_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.011_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/BOR.0000000000000024","article-title":"Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies","volume":"26","author":"Paik","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.011_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/rheumatology\/kes041","article-title":"Articular involvement in systemic sclerosis","volume":"51","author":"Avouac","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.011_bib14","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.011_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1756-185X.12100","article-title":"Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample","volume":"17","author":"Tedeschini","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10067-011-1930-z","article-title":"Anti-cyclic citrullinated peptide antibodies in scleroderma patients","volume":"31","author":"Polimeni","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.011_bib17","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/rheumatology\/keq205","article-title":"Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis","volume":"49","author":"Ueda-Hayakawa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rdc.2013.02.017","article-title":"Imaging of scleroderma","volume":"39","author":"Chapin","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.011_bib19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.21668","article-title":"Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings","volume":"64","author":"Elhai","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3899\/jrheum.080795","article-title":"Magnetic resonance imaging of the hand in systemic sclerosis","volume":"36","author":"Low","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/kes307","article-title":"Tendon friction rubs in systemic sclerosis: a possible explanation\u2013an ultrasound and magnetic resonance imaging study","volume":"52","author":"Stoenoiu","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/rheumatology\/kep464","article-title":"Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial","volume":"49","author":"Khanna","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/qjmed\/hct195","article-title":"Generalized calcinosis in systemic sclerosis","volume":"107","author":"Daumas","year":"2014","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.011_bib24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ard.2003.014431","article-title":"Low dose warfarin treatment for calcinosis in patients with systemic sclerosis","volume":"63","author":"Cukierman","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.011_bib25","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/rheumatology\/kes214","article-title":"Acro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis","volume":"51","author":"Johnstone","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.011_bib26","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3899\/jrheum.071171","article-title":"Vitamin D, parathyroid hormone, and acro-osteolysis in systemic sclerosis","volume":"35","author":"Braun-Moscovici","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.011_bib27","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3899\/jrheum.130032","article-title":"Low bone density in systemic sclerosis. A systematic review","volume":"40","author":"Omair","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.011_bib28","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2008.095919","article-title":"A\u00a0descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.011_bib29","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3899\/jrheum.121380","article-title":"The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review","volume":"40","author":"Muangchan","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib30","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/ar3888","article-title":"Aldolase predicts subsequent myopathy occurrence in systemic sclerosis","volume":"14","author":"Toledano","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.011_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00330-012-2584-1","article-title":"Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms","volume":"23","author":"Schanz","year":"2013","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2013.868512","article-title":"Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"2 Suppl 71","key":"10.1016\/j.rdc.2015.04.011_bib33","first-page":"S12","article-title":"Anti-PM-Scl antibody in patients with systemic sclerosis","volume":"30","author":"Koschik","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.011_bib34","first-page":"129","article-title":"Anti-PM\/Scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients","volume":"24","author":"Vandergheynst","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.011_bib35","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D'Aoust","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.011_bib36","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.011_bib37","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/ard.2008.092668","article-title":"Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.011_bib38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/ard.2006.060111","article-title":"Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study","volume":"66","author":"Nacci","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2 Suppl 71","key":"10.1016\/j.rdc.2015.04.011_bib39","first-page":"S55","article-title":"Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis","volume":"30","author":"Omair","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.011_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3899\/jrheum.100361","article-title":"Biologic therapy for systemic sclerosis: a systematic review","volume":"38","author":"Phumethum","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.011_bib41","first-page":"1636","article-title":"Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease","volume":"34","author":"Lam","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.011_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/annrheumdis-2012-202657","article-title":"Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study","volume":"72","author":"Elhai","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib43","first-page":"314","article-title":"Rituximab in rheumatoid arthritis: a systematic review of efficacy and safety","volume":"7","author":"Hernandez-Cruz","year":"2011","journal-title":"Reumatol Clin"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.011_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jhsa.2007.06.011","article-title":"Reconstructive hand surgery for scleroderma joint contractures","volume":"32","author":"Anandacoomarasamy","year":"2007","journal-title":"J\u00a0Hand Surg"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.011_bib45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-012-1940-5","article-title":"Intravenous immunoglobulin therapy in adult patients with polymyositis\/dermatomyositis: a systematic literature review","volume":"31","author":"Wang","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.rdc.2015.04.011_bib46","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.jaad.2007.06.010","article-title":"Discordant response to rituximab in a systemic sclerosis patient with associated myositis","volume":"58","author":"Fabri","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.011_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00296-007-0471-x","article-title":"The potential utility of B cell-directed biologic therapy in autoimmune diseases","volume":"28","author":"Arkfeld","year":"2008","journal-title":"Rheumatol Int"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:14:11Z","timestamp":1760181251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X15000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0889857X15000320"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.011","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Musculoskeletal Manifestations of Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}